Skip to main content

Pharma News

Pharma Courses

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • KemPharm, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted a fee waiver and has refunded the full user fee amount of $2,374,200 for its New Drug Application (NDA) filing for KP201/APAP, the Company’s investigational immediate release combination of its hydrocodone prodrug, KP201 (benzhydrocodone hydrochloride), and acetaminophen (APAP), which is currently under priority review by the FDA.  The FDA has set a target action date under the Prescription Drug User Fee Act of June 9, 2016.

  • MediciNova, Inc., and the JASDAQ Market of the Tokyo Stock Exchange announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a pending patent application which covers MN-001 (tipelukast) and MN-002 (a major metabolite of MN-001) for the treatment of hypertriglyceridemia, hypercholesterolemia, and hyperlipoproteinemia.

  • Focusing majorly on health, the Delhi government on Monday hiked its budgetary allocation for public health by Rs.472 crore over last year, and proposed a three-tier health system with opening of 1,000 mohalla (community) clinics and 150 polyclinics in various parts of the city.

  • The Chilean health ministry has confirmed the first case of sexually transmitted Zika virus in the country, the media reported on Sunday.The 46-year-old woman was infected with the virus as she had unprotected sex with her partner, who was infected with Zika in Haiti, said the ministry on Saturday.

  • Pregnant women with higher blood levels of a common plastic chemical used in the coatings of food containers are more likely to deliver their babies early compared with women with lower levels of that chemical, says a study led by an Indian-origin researcher.

Subscribe to Pharma News